Randomized Placebo Controlled Clinical Study of an Oral Product in Subjects With Menopausal Symptoms

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 10, 2024

Primary Completion Date

June 24, 2024

Study Completion Date

June 24, 2024

Conditions

Menopausal Symptoms

Interventions

DIETARY_SUPPLEMENT

Placebo

Eligible subjects will receive Placebo to take daily for five weeks

DIETARY_SUPPLEMENT

Dietary Supplement with Proprietary Herbal Extract Blend and GABA

Eligible subjects will receive active product to take daily for five weeks

Trial Locations (1)

See Final Report, San Francisco

All Listed Sponsors

lead

Olly, PBC

INDUSTRY

NCT06787443 - Randomized Placebo Controlled Clinical Study of an Oral Product in Subjects With Menopausal Symptoms | Biotech Hunter | Biotech Hunter